FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3095086994> ?p ?o ?g. }

• W3095086994 endingPage "106896" @default.
• W3095086994 startingPage "106896" @default.
• W3095086994 abstract "IgA nephropathy (IgAN) is the most prevalent primary glomerular disease worldwide and is responsible for 45–50% of primary glomerular diseases in China. We are essentially dependent on the degree of proteinuria to determine prognosis and it has been reported that histopathologic lesions are risk factors for the progression of IgAN. The aim of this study was to investigate the clinicopathologic features and prognosis of IgAN with C1q deposition in adult Chinese patients. The patients of primary IgAN diagnosed by renal biopsy from January 2002 to December 2018 at the Second Hospital of Shanxi Medical University were retrospectively analyzed and divided into C1q deposit group and C1q negative group according to glomerular immunofluorescence examination. We evaluated their serologic and histopathologic findings. We collected data of patients during January 1, 2015 to December 31, 2018 and performed the clinical follow-up until the patient's estimated glomerular filtration rate (eGFR) decreased by more than 30%, entering end-stage renal disease (ESRD). Kaplan-Meier survival analysis was used to evaluate the cumulative incidence of renal progression in two groups. Univariate and multivariate Cox proportional hazard regression models were used to analyze the effect of C1q deposition on the prognosis of patients with IgA nephropathy. The baseline data of total 491 cases were available and 172 cases had the follow-up data. The baseline eGFR and plasma albumin (ALB) levels in C1q deposit group were lower than those in the C1q negative group, while the levels of serum creatinine (Scr), total cholesterol (TC), 24 h urine protein, low-density lipoprotein (LDL), β2 microglobulin, etc. were higher than those in C1q negative group (all P < 0.05). Pathological indexes: glomerular segment sclerosis and adhesion (S), renal tubular atrophy/interstitial fibrosis (T), and cell/fibroblastic crescent (C) scores in C1q deposit group were higher than those in C1q negative group (all P < 0.05). With a median follow-up time of 32.5 (24,42) months, a total of 18 patients (C1q deposit: 11; C1q negative: 7) developed to endpoints. Kaplan-Meier survival curve analysis showed that there was significant decrease in cumulative incidence of renal progression between the two groups (Log-rank test χ2 = 4.78, P = 0.029). Cox regression analysis showed that the risk of renal end-point events in IgAN patients with C1q deposit group was 6.35 times higher than that in C1q negative group (HR = 6.35, 95% CI: 1.21–33.30, P = 0.029). The clinical and renal pathological changes of IgAN patients with C1q deposition are more severe than those of C1q negative patients, and has a worse outcome. C1q deposition is an independent risk factor for the progression of renal function and contributes to a poor renal prognosis in adult IgAN patients." @default.
• W3095086994 created "2020-11-09" @default.
• W3095086994 creator A5008313346 @default.
• W3095086994 creator A5022341028 @default.
• W3095086994 creator A5034940144 @default.
• W3095086994 creator A5078640432 @default.
• W3095086994 date "2020-11-01" @default.
• W3095086994 modified "2023-10-16" @default.
• W3095086994 title "Clinical and prognostic significance of C1q deposition in IgAN patients-a retrospective study" @default.
• W3095086994 cites W1217575213 @default.
• W3095086994 cites W1970106470 @default.
• W3095086994 cites W1971060717 @default.
• W3095086994 cites W1981055539 @default.
• W3095086994 cites W1982127939 @default.
• W3095086994 cites W1982967737 @default.
• W3095086994 cites W2017568050 @default.
• W3095086994 cites W2071111569 @default.
• W3095086994 cites W2074850565 @default.
• W3095086994 cites W2090996257 @default.
• W3095086994 cites W2110433136 @default.
• W3095086994 cites W2120366573 @default.
• W3095086994 cites W2122275740 @default.
• W3095086994 cites W2122512855 @default.
• W3095086994 cites W2123917517 @default.
• W3095086994 cites W2125558501 @default.
• W3095086994 cites W2135143233 @default.
• W3095086994 cites W2138161657 @default.
• W3095086994 cites W2140590997 @default.
• W3095086994 cites W2146064308 @default.
• W3095086994 cites W2148593462 @default.
• W3095086994 cites W2150719216 @default.
• W3095086994 cites W2162553150 @default.
• W3095086994 cites W2166885924 @default.
• W3095086994 cites W2167898282 @default.
• W3095086994 cites W2169743937 @default.
• W3095086994 cites W2292891914 @default.
• W3095086994 cites W2517246046 @default.
• W3095086994 cites W2602196428 @default.
• W3095086994 cites W2915476942 @default.
• W3095086994 cites W3016378846 @default.
• W3095086994 doi "https://doi.org/10.1016/j.intimp.2020.106896" @default.
• W3095086994 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/33182045" @default.
• W3095086994 hasPublicationYear "2020" @default.
• W3095086994 type Work @default.
• W3095086994 sameAs 3095086994 @default.
• W3095086994 citedByCount "2" @default.
• W3095086994 countsByYear W30950869942022 @default.
• W3095086994 countsByYear W30950869942023 @default.
• W3095086994 crossrefType "journal-article" @default.
• W3095086994 hasAuthorship W3095086994A5008313346 @default.
• W3095086994 hasAuthorship W3095086994A5022341028 @default.
• W3095086994 hasAuthorship W3095086994A5034940144 @default.
• W3095086994 hasAuthorship W3095086994A5078640432 @default.
• W3095086994 hasConcept C120665830 @default.
• W3095086994 hasConcept C121332964 @default.
• W3095086994 hasConcept C126322002 @default.
• W3095086994 hasConcept C126894567 @default.
• W3095086994 hasConcept C134018914 @default.
• W3095086994 hasConcept C144301174 @default.
• W3095086994 hasConcept C159641895 @default.
• W3095086994 hasConcept C167135981 @default.
• W3095086994 hasConcept C207103383 @default.
• W3095086994 hasConcept C2778653478 @default.
• W3095086994 hasConcept C2779561371 @default.
• W3095086994 hasConcept C2780091579 @default.
• W3095086994 hasConcept C2780306776 @default.
• W3095086994 hasConcept C2781184683 @default.
• W3095086994 hasConcept C38180746 @default.
• W3095086994 hasConcept C44249647 @default.
• W3095086994 hasConcept C50382708 @default.
• W3095086994 hasConcept C555293320 @default.
• W3095086994 hasConcept C61511704 @default.
• W3095086994 hasConcept C71924100 @default.
• W3095086994 hasConcept C72563966 @default.
• W3095086994 hasConcept C88879693 @default.
• W3095086994 hasConcept C90924648 @default.
• W3095086994 hasConceptScore W3095086994C120665830 @default.
• W3095086994 hasConceptScore W3095086994C121332964 @default.
• W3095086994 hasConceptScore W3095086994C126322002 @default.
• W3095086994 hasConceptScore W3095086994C126894567 @default.
• W3095086994 hasConceptScore W3095086994C134018914 @default.
• W3095086994 hasConceptScore W3095086994C144301174 @default.
• W3095086994 hasConceptScore W3095086994C159641895 @default.
• W3095086994 hasConceptScore W3095086994C167135981 @default.
• W3095086994 hasConceptScore W3095086994C207103383 @default.
• W3095086994 hasConceptScore W3095086994C2778653478 @default.
• W3095086994 hasConceptScore W3095086994C2779561371 @default.
• W3095086994 hasConceptScore W3095086994C2780091579 @default.
• W3095086994 hasConceptScore W3095086994C2780306776 @default.
• W3095086994 hasConceptScore W3095086994C2781184683 @default.
• W3095086994 hasConceptScore W3095086994C38180746 @default.
• W3095086994 hasConceptScore W3095086994C44249647 @default.
• W3095086994 hasConceptScore W3095086994C50382708 @default.
• W3095086994 hasConceptScore W3095086994C555293320 @default.
• W3095086994 hasConceptScore W3095086994C61511704 @default.
• W3095086994 hasConceptScore W3095086994C71924100 @default.
• W3095086994 hasConceptScore W3095086994C72563966 @default.
• W3095086994 hasConceptScore W3095086994C88879693 @default.

• next